Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial "SHINE"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial is a multicenter, randomized, controlled clinical trial of 1400 patients that will include approximately 60 enrolling sites. The study hypotheses are that treatment of hyperglycemic acute ischemic stroke patients with targeted glucose concentration (80mg/dL - 130 mg/dL) will be safe and result in improved 3 month outcome after stroke. Eligible...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 November 2017.

1 Apr 2012 6 Jun 2011 1 Mar 2020 1 Jun 2020 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All